JP2014530010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530010A5 JP2014530010A5 JP2014533316A JP2014533316A JP2014530010A5 JP 2014530010 A5 JP2014530010 A5 JP 2014530010A5 JP 2014533316 A JP2014533316 A JP 2014533316A JP 2014533316 A JP2014533316 A JP 2014533316A JP 2014530010 A5 JP2014530010 A5 JP 2014530010A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- protein
- arginine
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000725643 Respiratory syncytial virus Species 0.000 claims 26
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 17
- 239000004475 Arginine Substances 0.000 claims 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 102000004961 Furin Human genes 0.000 claims 4
- 108090001126 Furin Proteins 0.000 claims 4
- 238000003776 cleavage reaction Methods 0.000 claims 4
- 230000007017 scission Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 230000010076 replication Effects 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 101710085938 Matrix protein Proteins 0.000 claims 1
- 101710127721 Membrane protein Proteins 0.000 claims 1
- 101710141454 Nucleoprotein Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161542040P | 2011-09-30 | 2011-09-30 | |
| US61/542,040 | 2011-09-30 | ||
| US201161542721P | 2011-10-03 | 2011-10-03 | |
| US61/542,721 | 2011-10-03 | ||
| US201261611834P | 2012-03-16 | 2012-03-16 | |
| US61/611,834 | 2012-03-16 | ||
| US201261614286P | 2012-03-22 | 2012-03-22 | |
| US61/614,286 | 2012-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530010A JP2014530010A (ja) | 2014-11-17 |
| JP2014530010A5 true JP2014530010A5 (enExample) | 2016-09-29 |
Family
ID=47996397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533316A Pending JP2014530010A (ja) | 2011-09-30 | 2012-09-27 | 呼吸器合胞体ウイルス用の組み換えナノ粒子ｒｓｖｆワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20130122032A1 (enExample) |
| EP (1) | EP2760469A4 (enExample) |
| JP (1) | JP2014530010A (enExample) |
| KR (1) | KR20140077169A (enExample) |
| CN (2) | CN105381457A (enExample) |
| AU (1) | AU2013201495B2 (enExample) |
| BR (1) | BR112014007616A2 (enExample) |
| CA (1) | CA2849471A1 (enExample) |
| HK (1) | HK1222125A1 (enExample) |
| IL (1) | IL231637A0 (enExample) |
| MX (1) | MX2014003777A (enExample) |
| RU (1) | RU2014117068A (enExample) |
| SG (2) | SG11201400999VA (enExample) |
| WO (1) | WO2013049342A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010077717A1 (en) | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Modified rsv f proteins and methods of their use |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| BR112015025392A2 (pt) * | 2013-04-08 | 2017-10-10 | Medimmune Llc | composição de vacina e método de utilização |
| CA2925201A1 (en) * | 2013-09-24 | 2015-04-02 | Massachusetts Institute Of Technology | Self-assembled nanoparticle vaccines |
| CN105087643A (zh) * | 2014-04-16 | 2015-11-25 | 中国科学院上海巴斯德研究所 | 重组表达人呼吸道合胞病毒f1蛋白胞外区的方法及表达系统 |
| US10100372B2 (en) | 2014-06-18 | 2018-10-16 | Georgia State University Research Foundation, Inc. | Recombinant RSV reporter virus |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| EP3344290A4 (en) * | 2015-08-31 | 2019-02-27 | Technovax, Inc. | VACCINE BASED ON VIRUS-LIKE PARTICLES OF HUMAN RESPIRATORY SYNZYTIAL VIRUS (HRSV) |
| AU2016316723B2 (en) * | 2015-09-02 | 2021-03-25 | Janssen Vaccines & Prevention B.V. | Stabilized viral class I fusion proteins |
| MX2018002728A (es) * | 2015-09-03 | 2018-09-05 | Novavax Inc | Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas. |
| CN106547635B (zh) | 2015-09-18 | 2020-10-09 | 阿里巴巴集团控股有限公司 | 一种作业的操作重试方法和装置 |
| MY205060A (en) | 2015-12-23 | 2024-09-30 | Pfizer | Rsv f protein mutants |
| KR20220041966A (ko) * | 2016-04-05 | 2022-04-01 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 용해성 융합-전 rsv f 단백질 |
| CN106124767A (zh) * | 2016-05-12 | 2016-11-16 | 广州瑞辉生物科技股份有限公司 | 呼吸道合胞病毒IgA抗体检测试纸条及其检测方法 |
| WO2018067300A1 (en) * | 2016-10-03 | 2018-04-12 | University Of Massachusetts | Methods for immunizing pre-immune subjects against respiratory syncytial virus (rsv) |
| WO2018170238A2 (en) * | 2017-03-15 | 2018-09-20 | Novavax, Inc. | Methods and compositions for inducing immune responses against clostridium difficile |
| CN110603262A (zh) | 2017-04-04 | 2019-12-20 | 华盛顿大学 | 显示副粘病毒和/或肺炎病毒f蛋白的自组装蛋白纳米结构及其用途 |
| CN107050446B (zh) * | 2017-04-19 | 2020-08-11 | 武汉博沃生物科技有限公司 | 经修饰的季节流感-rsv联合疫苗及其制备方法 |
| CN111148509A (zh) | 2017-07-24 | 2020-05-12 | 诺瓦瓦克斯股份有限公司 | 治疗呼吸系统疾病的方法和组合物 |
| WO2019063844A1 (en) * | 2017-09-29 | 2019-04-04 | Universiteit Antwerpen | VACCINATION AGAINST SYNCYTIAL RESPIRATORY VIRUS |
| AU2019228551B2 (en) | 2018-02-28 | 2025-07-24 | University Of Washington | Self-assembling nanostructure vaccines |
| IL277274B2 (en) | 2018-03-19 | 2024-02-01 | Novavax Inc | Multifunctional nanoparticle vaccines for influenza |
| KR102567994B1 (ko) * | 2018-10-12 | 2023-08-17 | 에스케이바이오사이언스(주) | 재조합 rsv 생백신주 및 이의 제조 방법 |
| EP3873517A4 (en) * | 2018-10-29 | 2022-09-28 | Emory University | RSV VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF |
| KR102725189B1 (ko) * | 2018-11-01 | 2024-10-31 | 에스케이바이오사이언스(주) | 재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물 |
| WO2020175660A1 (ja) * | 2019-02-28 | 2020-09-03 | Ｋｍバイオロジクス株式会社 | Ｒｓｖ ｆ／ｇキメラワクチン |
| CN110229219B (zh) * | 2019-06-21 | 2021-03-30 | 中国科学院武汉病毒研究所 | 一种新型的呼吸道合胞病毒疫苗抗原的制备方法及其用途 |
| TW202142555A (zh) * | 2020-01-27 | 2021-11-16 | 美商諾瓦瓦克斯股份有限公司 | 冠狀病毒疫苗配製品 |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| CN115461076A (zh) * | 2020-04-02 | 2022-12-09 | 扬森疫苗与预防公司 | 稳定化的疫苗组合物 |
| CN113855796B (zh) * | 2021-07-30 | 2024-01-26 | 河北医科大学 | 卡介苗作为呼吸道合胞病毒灭活疫苗佐剂的应用 |
| TW202330922A (zh) * | 2021-11-19 | 2023-08-01 | 美商Ｒｎａ免疫公司 | 核糖核酸呼吸道融合病毒(rsv)疫苗之組合物及方法 |
| KR102785012B1 (ko) * | 2021-12-14 | 2025-03-20 | 경희대학교 산학협력단 | Rsv 항원 단백질을 포함하는 바이러스 유사입자 및 이를 이용한 백신 |
| WO2024050015A1 (en) * | 2022-09-01 | 2024-03-07 | Novavax, Inc. | Downstream process for purification of viral proteins with hydrophobic membrane domain for use in vaccine compositions |
| CN117986382B (zh) * | 2022-11-04 | 2025-04-01 | 北京康乐卫士生物技术股份有限公司 | 针对rsv的重组亚单位疫苗及其应用 |
| WO2024259624A1 (en) * | 2023-06-21 | 2024-12-26 | Shenzhen Genius Biotech Service Co. Ltd | A modified rsv f protein, a nanoparticle, a composition and a vaccine against respiratory syncytial virus infection |
| WO2024260446A1 (zh) * | 2023-06-21 | 2024-12-26 | 深圳深信生物科技有限公司 | 呼吸道合胞病毒(rsv)疫苗 |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| WO2025051250A1 (zh) * | 2023-09-07 | 2025-03-13 | 北京科兴中维生物技术有限公司 | 呼吸道合胞病毒f蛋白及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813061B (zh) * | 2003-04-25 | 2013-05-29 | 免疫医疗有限责任公司 | 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗 |
| WO2008114149A2 (en) * | 2007-03-21 | 2008-09-25 | Id Biomedical Corporation Of Quebec | Chimeric antigens |
| DK2540312T3 (en) * | 2007-07-19 | 2015-07-20 | Novavax Inc | Chimeric avian influenza VLPs |
| JP5711972B2 (ja) * | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
| JP2011514337A (ja) * | 2008-02-25 | 2011-05-06 | ノババックス，インコーポレイテッド | 糖ガラス化ウィルス様粒子（ｖｌｐ） |
| KR101027159B1 (ko) * | 2008-07-28 | 2011-04-05 | 뮤추얼아이피서비스(주) | 타겟 영상 검출 장치 및 그 방법 |
| WO2010077712A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Bovine respiratory syncytial virus virus-like particle (vlps) |
| WO2010077717A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Modified rsv f proteins and methods of their use |
-
2012
- 2012-09-27 JP JP2014533316A patent/JP2014530010A/ja active Pending
- 2012-09-27 EP EP12835033.7A patent/EP2760469A4/en not_active Withdrawn
- 2012-09-27 CA CA2849471A patent/CA2849471A1/en not_active Abandoned
- 2012-09-27 SG SG11201400999VA patent/SG11201400999VA/en unknown
- 2012-09-27 RU RU2014117068/10A patent/RU2014117068A/ru not_active Application Discontinuation
- 2012-09-27 KR KR1020147009538A patent/KR20140077169A/ko not_active Withdrawn
- 2012-09-27 US US13/629,107 patent/US20130122032A1/en not_active Abandoned
- 2012-09-27 BR BR112014007616A patent/BR112014007616A2/pt active Search and Examination
- 2012-09-27 WO PCT/US2012/057546 patent/WO2013049342A1/en not_active Ceased
- 2012-09-27 CN CN201510769961.3A patent/CN105381457A/zh active Pending
- 2012-09-27 AU AU2013201495A patent/AU2013201495B2/en not_active Ceased
- 2012-09-27 MX MX2014003777A patent/MX2014003777A/es unknown
- 2012-09-27 CN CN201280059282.1A patent/CN104080476A/zh active Pending
- 2012-09-27 SG SG10201602434UA patent/SG10201602434UA/en unknown
-
2014
- 2014-03-20 IL IL231637A patent/IL231637A0/en unknown
-
2015
- 2015-02-27 US US14/634,171 patent/US20150306207A1/en not_active Abandoned
- 2015-02-27 US US14/634,162 patent/US20150335730A1/en not_active Abandoned
-
2016
- 2016-08-31 HK HK16110329.3A patent/HK1222125A1/zh unknown
-
2017
- 2017-02-15 US US15/433,759 patent/US20170319682A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530010A5 (enExample) | ||
| RU2014117068A (ru) | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса | |
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Boyoglu-Barnum et al. | Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice | |
| US12162907B2 (en) | Subunit vaccine for treatment or prevention of a respiratory tract infection | |
| Elkashif et al. | Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections | |
| RU2015138530A (ru) | Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа | |
| Haynes | Progress and challenges in RSV prophylaxis and vaccine development | |
| Stepanova et al. | Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes | |
| JP2015509707A5 (enExample) | ||
| RU2011128371A (ru) | Модифицированные f протеины sv и способы их применения | |
| JP2014502156A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2015536134A5 (enExample) | ||
| JP2016510983A5 (enExample) | ||
| HRP20240996T1 (hr) | Prefuzija rsv f proteina i njihova uporaba | |
| JP2016510983A (ja) | 呼吸器合胞体ウイルスの熱安定な融合前ｆタンパク質オリゴマーおよび免疫組成物におけるその使用 | |
| JP2015517489A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| Kotomina et al. | Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease | |
| BR112014015390A8 (pt) | vírus da estomatite vesicular para vacinas iniciais e de reforço | |
| JP2015506705A5 (enExample) | ||
| JP2013518052A5 (enExample) | ||
| JP2015500827A5 (enExample) |